Merck (NYSE: MRK) reported Q3 EPS of $0.96, $0.04 better than the analyst estimate of $0.92. Revenue for the quarter came in at $10.1 billion versus the consensus estimate of $10.11 billion.

Merck sees FY2015 EPS of $3.55-$3.60, versus prior guidance of $3.45-$3.55 and the consensus of $3.51.

For earnings history and earnings-related data on Merck (MRK) click here.